Correction: Carbon quantum dots of ginsenoside Rb1 for application in a mouse model of intracerebral hemorrhage

Xiaolong Tang, Xinyu Yang, Yamei Yu, Miaojing Wu, Yuanyuan Li, Zhe Zhang, Guangyu Jia, Qi Wang, Wei Tu, Ye Wang, Xingen Zhu, Shiyong LiJournal of Nanobiotechnology 2024 · DOI · OpenAlex

This document serves as a formal correction notice for a research article originally published in the Journal of Nanobiotechnology. The primary purpose of this update is to rectify administrative errors regarding the institutional affiliations of the research team involved in the study of ginsenoside-derived carbon quantum dots.

Overview of the Correction

In the original publication, the affiliations for the contributing authors—representing departments of neurosurgery, neurology, and neuroscience—were incorrectly listed. Maintaining the accuracy of the academic record is vital for institutional rankings, funding accountability, and ensuring that researchers receive proper credit within their specific clinical and academic departments.

The correction notice ensures the scientific record is up to date.

Corrected Affiliations

The research was a collaborative effort primarily between several departments at Nanchang University and its Second Affiliated Hospital. The corrected affiliation list is as follows:

  1. Department of Neurosurgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, 330006, China.
  2. Institute of Neuroscience, Nanchang University, Nanchang, Jiangxi, 330006, China.
  3. Department of Neurology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, 330006, China.

Scientific Context: Intracerebral Hemorrhage and CQDs

While this specific notice focuses on metadata, the underlying research addresses intracerebral hemorrhage (ICH), a severe form of stroke characterized by high mortality and significant brain injury. The study investigated the therapeutic potential of Carbon Quantum Dots (CQDs) derived from ginsenoside Rb1, a major pharmacological component of ginseng.

These nanoparticles, typically less than 10 nm in size, were explored as a novel nanomedicine intervention. The interdisciplinary nature of this work is highlighted by the equal contributions of four lead researchers (Xiaolong Tang, Xinyu Yang, Yamei Yu, and Miaojing Wu), bridging the gap between materials science and clinical neurology.

Conclusion

The original article has been officially updated in the publisher's database to reflect these institutional changes. This correction ensures that the geographical and academic attribution for this nanobiotechnology research is accurate and transparent.

Summary updated

BibTeX
@article{tang2024correction,
  author = {Xiaolong Tang and Xinyu Yang and Yamei Yu and Miaojing Wu and Yuanyuan Li and Zhe Zhang and Guangyu Jia and Qi Wang and Wei Tu and Ye Wang and Xingen Zhu and Shiyong Li},
  title = {{Correction: Carbon quantum dots of ginsenoside Rb1 for application in a mouse model of intracerebral hemorrhage}},
  journal = {Journal of Nanobiotechnology},
  year = {2024},
  doi = {10.1186/s12951-024-02497-2},
}
Figure